Source: BrainStorm Cell Therapeutics
Posted: February 14, 2007 08:30 AM EST
Summary:
BrainStorm Cell Therapeutics, a leader in Adult Stem Cell Research, announced today that it has initiated a safety trial using an animal model of Parkinson’s disease in primates.
